Although the application of medical cannabinoid drugs is controversial, it is a part of modern-day medicine. The list of diseases in which cannabinoids are promoted as a treatment is constantly expanding. Cases of significant improvement in patients have been described as anecdotal at best. In this talk, Chandni will outline the current evidence based for cannabidiol and integrate the current public and governmental perspective on cannabidiol.
Chandni Hindocha, NIHR/BRC Research Fellow, Clinical Psychopharmacology Unit, Division of Psychiatry, University College London
Tuesday 28th April 7.00 pm Members free/Non-members £5